Abcam Plc (LON:ABC)‘s stock had its “sell” rating reissued by analysts at Panmure Gordon in a research note issued on Monday.
Several other equities research analysts have also issued reports on ABC. Peel Hunt reissued a “hold” rating and set a GBX 750 ($9.69) target price on shares of Abcam Plc in a research note on Monday. Numis Securities Ltd reissued an “add” rating and set a GBX 1,116 ($14.41) target price on shares of Abcam Plc in a research note on Thursday, July 27th. Finally, Berenberg Bank began coverage on shares of Abcam Plc in a research note on Tuesday, June 27th. They set a “buy” rating and a GBX 1,100 ($14.21) target price on the stock. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of GBX 900 ($11.62).
Abcam Plc (LON:ABC) opened at 1067.00 on Monday. Abcam Plc has a one year low of GBX 725.50 and a one year high of GBX 1,090.00. The company’s market capitalization is GBX 2.16 billion. The company has a 50-day moving average price of GBX 1,046.70 and a 200-day moving average price of GBX 948.29.
About Abcam Plc
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.
Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with MarketBeat.com's FREE daily email newsletter.